Results 101 to 110 of about 2,854 (152)

Low HDL-The Challenge. [PDF]

Clin Med Res
Rezkalla SH, Kloner RA.
europepmc   +1 more source

Efeitos pleiotrópicos das estatinas na sepse

, 2014
Kelly Cristina Batista de Souto Queiroz, Luiz Carlos de Abreu, Mônica Akemi Sato, Rodrigo Daminello Raimundo, Silvana Menegoto Nogueira Di Giusto   +4 more
core   +1 more source

A disproportionality analysis on proprotein convertase subtilisin/kexin type 9 inhibitors and hypersensitivity and anaphylaxis. [PDF]

Sci Rep
Dermiki-Gkana F, Gravel CA, Kontogiorgis C, Douros A.   +3 more
europepmc   +1 more source

Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL clearance and regress atherosclerosis on atorvastatin background. [PDF]

J Lipid Res
Inia JA, Zhang LH, Keijzer N, Worms N, van Nieuwkoop-van Straalen A, Ditmarsch M, de Kleer M, Jukema JW, Kastelein JJP, Szarek M, van den Hoek AM, Stokman G, Pieterman EJ, Princen HMG.   +13 more
europepmc   +1 more source

<i>Proprotein Convertase Subtilisin</i>/<i>Kexin Type 9</i> (<i>PCSK9</i>) Inhibitor Therapy Reduces the Level of DNA Damage in Patients with Heterozygous Familial Hypercholesterolemia. [PDF]

Int J Mol Sci
Woźniak E, Woźniak A, Pawlos A, Broncel M, Satała J, Bukowska B, Gorzelak-Pabiś P.   +6 more
europepmc   +1 more source

Rationale, design, and baseline characteristicss of the effect of PCSK9 inhibition on cardiovascular risk in treated HIV infection: EPIC-HIV randomized clinical trial. [PDF]

Am Heart J
Durstenfeld MS, Levkova-Clark M, Li D, Schaffer V, Abohashem S, Ma Y, Kawai K, Lu MT, Sereti I, Deeks SG, Tawakol A, Hsue PY.   +11 more
europepmc   +1 more source

Attainment of low-density lipoprotein cholesterol goals in patients undergoing coronary revascularization in the contemporary clinical practice. [PDF]

Indian Heart J
Bansal M, Kasliwal RR, Chandra P, Kapoor R, Chouhan N, Bhan A, Trehan N.   +6 more
europepmc   +1 more source

LDL-C Goal Attainment with Fixed-Dose Ezetimibe and Atorvastatin Versus High-Dose Atorvastatin in Chinese Patients: Subgroup Analysis of a Randomized Trial. [PDF]

Adv Ther
Qian J, Zhang X, Chen J, Ding C, Yang P, Qing L, Liu Y, Chen SS, Ge J.   +8 more
europepmc   +1 more source

Physician Disagreement With Guidelines as a Critical Barrier to Achieving LDL-C Targets in Very High-Risk Patients: An Implementation Science Study. [PDF]

J Korean Med Sci
Cho KH, Cho YR, Lee SR, Bae JW, Nam CW, Park Y, Hwang JY, Yun KH, Kim W, Kim MC, Sim DS, Hong YJ, Kim JH, Ahn Y, Hahn JY, Jeong MH.   +15 more
europepmc   +1 more source

Treatment pathways of lipid-lowering therapies in Germany 2016-2022. [PDF]

Clin Res Cardiol
Katzmann JL, Grellmann C, Leppert B, Müller-Kozarez I, Schulz M, Laufs U.   +5 more
europepmc   +1 more source